Receptor agonist activity is not a requirement for muscarinic antinociception

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 2, 1997, Pages 868-875

  Sheardown, Malcolm J ^a   Shannon, Harlan E ^b   Swedberg, Michael D B ^a   Suzdak, Peter D ^a   Bymaster, Frank P ^b   Olesen, Preben H ^a   Mitch, Charles H ^b   Ward, John S ^b   Sauerberg, Per ^a  

^a NOVO NORDISK A S   (Denmark)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 8 METHYL 2,8 DIAZASPIRO[4.5]DECANE 1,3 DIONE; ACECLIDINE; ACETIC ACID; ARECOLINE; METHYLSCOPOLAMINE; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; NALTREXONE; OXOTREMORINE; PILOCARPINE; PIRENZEPINE; SCOPOLAMINE; THIADIAZOLE DERIVATIVE; XANOMELINE; ANALGESIC AGENT; INOSITOL PHOSPHATE; SCOPOLAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CELL STRAIN BHK; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; HOT PLATE TEST; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; RABBIT; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST; VAS DEFERENS; WRITHING TEST; ANIMAL; CELL LINE; DRUG EFFECT; GENETIC TRANSFECTION; GUINEA PIG; HAMSTER; HEART ATRIUM; HEART ATRIUM FUNCTION; HUMAN; HYDROLYSIS; IN VITRO STUDY; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; WISTAR RAT;

ANALGESICS; ANIMALS; ATRIAL FUNCTION; CELL LINE; CRICETINAE; GUINEA PIGS; HEART ATRIA; HUMANS; HYDROLYSIS; INOSITOL PHOSPHATES; MALE; MICE; MUSCARINIC AGONISTS; MUSCLE CONTRACTION; N-METHYLSCOPOLAMINE; NALTREXONE; RABBITS; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M1; RECEPTORS, MUSCARINIC; SCOPOLAMINE; SCOPOLAMINE DERIVATIVES; TRANSFECTION; VAS DEFERENS;

EID: 0030610428     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. BIRDSALL, N. J., CHAN, S. C., EVELEIGH, P., HULME, E. C. AND MILLER, K. W.: The modes of binding of ligands to cardiac muscarinic receptors. Trends. Pharmacol. Sci. 10(suppl): 31-34, 1989.
2. BONNER, T. I., BUCKLEY, N. J., YOUNG, A. C. AND BRANN, M. R.: Identification of a family of muscarinic acetylcholine receptor genes. Science 237: 527-532, 1987.
3. BUCKLEY, N. J., BONNER, T. I. AND BRANN, M. R.: Localization of a family of muscarinic receptor mRNAs in rat brain. J. Neurosci. 8: 4646-4652, 1988.
4. CHEN, G.: The anti-tremorine effect of some drugs as determined by Hoffner's method of testing analgesia in mice. J. Pharmacol. Exp. Ther. 124: 73-76, 1958.
5. CLAGUE, R. U., EGLEN, R. M., STRACHAN, A. C. AND WHITING, R. L.: Action of agonists and antagonists at muscarinic receptors present on ileum and atria in vitro. Br. J. Pharmacol. 86: 163-170, 1985.
6. DAWSON, G. R., JOHNSTONE, S., BOYLEY, P. AND IVERSEN, S. D.: The effects of a novel muscarinic receptor agonist, L-689,666 in the mouse tail-flick test of antinociception. Br. J. Pharmacol. 104: suppl., 458P, 1991.
7. DOODS, H. N., ENTZEROTH, M. ZIEGLER, H., MAYER, N. AND HOLZER, B.: Pharmacological profile of selective muscarinic receptor antagonists on guinea pig ileal smooth-muscle. Eur. J. Pharmacol. 253: 275-281, 1994.
8. 3 receptors in guinea pig ileum and atria in vitro. Br. J. Pharmacol. 64: 293-300, 1993.
9. 1-type. Eur. J. Pharmacol. 158: 233-242, 1988.
10. FORD, A. P. D. W., LEVINE, W. B., BASTER, G. S., HARRIS, G. C., EGLEN, R. M. AND WHITING, R. L.: Pharmacological, biochemical and molecular characterisation of muscarinic receptors in the guinea pig ileum: a multidisciplinary study. Mol. Neuropharmacol. 1: 117-127, 1991.
11. 1 receptors. Eur. J. Pharmacol. 183: 1941-1942, 1990.
12. GILLBERG, P. G. AND ASKMARK, H.: Changes in cholinergic and opioid receptors in the rat spinal cord, dorsal root and sciatic nerve after ventral and dorsal root lesion. J. Neural Transm. 85: 31-39, 1991.
13. HARRIS, L. S., DEWEY, W. L., HOWES, J. F., KENNEDY, J. S. AND PARS, H.: Narcotic antagonist analgesics: interactions with cholinergic systems. J. Pharmacol. Exp. Ther. 169: 17-22, 1969.
14. HARTVIG, P., GILLBERG, P. G., GORDH, T. JR. AND POST C.: Cholinergic mechanisms in pain and analgesia. Trends Pharmacol. Sci. 10(suppl): 75-79, 1989.
15. HERZ, A.: Actions of arecoline on the central nervous system. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmacol. 242: 414-429, 1962.
16. HONDA, K., TAKAKO, Y. AND KAMIYA, H.: Pharmacological profiles of muscarinic receptors in the longitudinal smooth-muscle of guinea pig ileum. Jpn. J. Pharmacol. 62: 43-47, 1993.
17. IRESON, J. D.: A comparison of the antinociceptive actions of cholinomimetic and morphine-like drugs. Br. J. Pharmacol. 40: 92-101, 1970.
18. IWAMOTO, E. T. AND MARION, L.: Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats. J. Pharmacol. Exp. Ther. 266: 329-339, 1993.
19. IWAMOTO, E. T., MARION, L., PEDIGO, N. W. AND GUARINO, R. D.: Muscarinic cholinergic spinal antinociception. Soc. Neurosci. Abstr. 18: 428.12, 1992.
20. LEVEY, A. I.: Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci. 52: 441-448, 1993.
21. LEVEY, A. I., KITT, C. A., SIMONDS, W. F., PRICE, D. L. AND BRANN, M. R.: Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J. Neurosci. 11: 3218-3226, 1991.
22. METYS, J., WAGNER, N., METYSOVA, J. AND HERZ, A.: Studies in central antinociceptive action of cholinomimetic agents. Int. J. Neuropharmacol. 8: 413-425, 1969.
23. 2 receptors in longitudinal muscle membranes. Eur. J. Pharmacol. 145: 305-311, 1988.
24. PEDIGO, N. W., DEWEY, W. L. AND HARRIS, L. S.: Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice. J. Pharmacol. Exp. Ther. 193: 845-852, 1975.
25. PETERSSON, J., GORDH, T. E., HARTVIG, P. AND WIKLUND, L.: A double-blind trial of the analgesic properties of physostigmine in postoperative patients. Acta Aneasthesiol. Scand. 30: 283-288, 1986.
26. SAUERBERG, P., KINDTLER, J. W., NIELSEN, S., SHEARDOWN, M. J. AND HONORÉ, T.: Muscarinic cholinergic agonists and antagonists of the 3-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine type. Synthesis and structure activity relationships. J. Med. Chem. 34: 687-692, 1991.
27. 1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines. J. Med. Chem. 35: 2274-2283, 1992.
28. 1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens. Eur. J. Pharmacol. 232: 47-57, 1993.
29. 32P] incorporation into phosphorylated metabolites in cultured cells. Anal. Biochem. 124: 421-425, 1982.
30. STONE, V., MOON, W. AND SHOW, F. H.: Treatment of intractable pain with morphine and tetrahydroaminoacridine. Br. Med. J. 18: 471-473, 1961.
31. SWEDBERG, M. D. B.: The mouse grid-shock analgesia test: pharmacological characterization of latency to vocalization threshold as an index of antinociception. J. Pharmacol. Exp. Ther. 269: 1021-1028, 1994.
32. 1 muscarinic receptors (Abstract). Life Sci. 52: 594, 1993.
33. WIDMAN, M., TUCKER, S., BRASE, D. A. AND DEWEY, W. L.: Cholinergic agents: antinociception without morphine-type dependence in rats. Life Sci. 36: 2007-2015, 1985.